Low doses of cholera toxin and its mediator cAMP induce CTLA-2 secretion by dendritic cells to enhance regulatory T cell conversion.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28759565)

Published in PLoS One on July 31, 2017

Authors

Cinthia Silva-Vilches1, Katrien Pletinckx1, Miriam Lohnert1, Vladimir Pavlovic1, Diyaaeldin Ashour1, Vini John1, Emilia Vendelova1, Susanne Kneitz1,2, Jie Zhou3, Rena Chen3, Thomas Reinheckel4, Thomas D Mueller5, Jochen Bodem1, Manfred B Lutz1

Author Affiliations

1: Institute of Virology and Immunobiology, University of Wuerzburg, Wuerzburg, Germany.
2: Department of Physiological Chemistry, University of Wuerzburg, Wuerzburg, Germany.
3: BioLegend Inc., San Diego, California, United States of America.
4: Institute of Molecular Medicine and Cell Research, and BIOSS Centre for Biological Signaling Studies, University of Freiburg, Freiburg, Germany.
5: Department of Molecular Plant Physiology and Biophysics, University of Wuerzburg, Wuerzburg, Germany.

Articles cited by this

IL-17 and Th17 Cells. Annu Rev Immunol (2009) 23.02

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods (1999) 17.06

Tolerogenic dendritic cells. Annu Rev Immunol (2001) 13.77

Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol (2010) 11.80

Th17 and regulatory T cells in mediating and restraining inflammation. Cell (2010) 5.89

Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol (2003) 5.54

Dendritic cell regulation of TH1-TH2 development. Nat Immunol (2000) 5.13

Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat Immunol (2000) 5.13

Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol (2005) 5.09

Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol (2009) 4.90

Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol (2002) 4.64

T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol Today (1999) 4.49

Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J Cell Biol (1988) 4.34

Basophils contribute to T(H)2-IgE responses in vivo via IL-4 production and presentation of peptide-MHC class II complexes to CD4+ T cells. Nat Immunol (2009) 3.82

IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. J Clin Invest (2004) 3.69

T(H)1 cells control themselves by producing interleukin-10. Nat Rev Immunol (2007) 3.65

Latent TGF-β structure and activation. Nature (2011) 3.42

Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur J Immunol (1996) 3.24

Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J Immunol (1995) 2.87

Divergent expression patterns of IL-4 and IL-13 define unique functions in allergic immunity. Nat Immunol (2011) 2.67

Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective. Nat Rev Immunol (2009) 2.65

Development and maintenance of regulatory T cells. Immunity (2013) 2.61

Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen. J Exp Med (1994) 2.41

Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J Exp Med (2002) 2.37

CD11c depletion severely disrupts Th2 induction and development in vivo. J Exp Med (2010) 2.26

Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling. FASEB J (2000) 2.09

The interplay between the duration of TCR and cytokine signaling determines T cell polarization. Eur J Immunol (1999) 2.02

Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming. Eur J Immunol (2000) 1.85

Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor beta1 and beta2 chain expression. J Exp Med (1999) 1.58

Mucosal adjuvant activity of cholera toxin requires Th17 cells and protects against inhalation anthrax. Proc Natl Acad Sci U S A (2010) 1.49

Cholera toxin: a paradigm for multi-functional engagement of cellular mechanisms (Review). Mol Membr Biol (2004) 1.49

Intranasal delivery of cholera toxin induces th17-dominated T-cell response to bystander antigens. PLoS One (2009) 1.46

Human cathepsin V functional expression, tissue distribution, electrostatic surface potential, enzymatic characterization, and chromosomal localization. Biochemistry (1999) 1.38

LTBPs, more than just an escort service. J Cell Biochem (2012) 1.37

Functions of toll-like receptors: lessons from KO mice. C R Biol (2004) 1.36

T-cell-receptor-dependent signal intensity dominantly controls CD4(+) T cell polarization In Vivo. Immunity (2014) 1.28

Development of dendritic cell-based immunotherapy for autoimmunity. Int Rev Immunol (2010) 1.24

Cholera toxin promotes the induction of regulatory T cells specific for bystander antigens by modulating dendritic cell activation. J Immunol (2003) 1.24

The cellular and molecular mechanisms of immuno-suppression by human type 1 regulatory T cells. Front Immunol (2012) 1.23

Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit. Scand J Immunol (2010) 1.23

Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease. Clin Exp Immunol (2004) 1.16

Novel structures CTLA-2 alpha and CTLA-2 beta expressed in mouse activated T cells and mast cells and homologous to cysteine proteinase proregions. Eur J Immunol (1989) 1.15

A differential molecular biology search for genes preferentially expressed in functional T lymphocytes: the CTLA genes. Immunol Rev (1988) 1.13

Quantitative events determine the differentiation and function of helper T cells. Nat Immunol (2011) 1.13

Functional analysis of cathepsin B-like cysteine proteases from Leishmania donovani complex. Evidence for the activation of latent transforming growth factor beta. J Biol Chem (2002) 1.09

Cathepsin L is involved in cathepsin D processing and regulation of apoptosis in A549 human lung epithelial cells. Biol Chem (2004) 1.06

Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis. J Clin Invest (2003) 1.04

Retinal pigment epithelium-derived CTLA-2alpha induces TGFbeta-producing T regulatory cells. J Immunol (2008) 1.03

Steady state migratory RelB+ langerin+ dermal dendritic cells mediate peripheral induction of antigen-specific CD4+ CD25+ Foxp3+ regulatory T cells. Eur J Immunol (2011) 1.03

Therapeutic potential of semi-mature dendritic cells for tolerance induction. Front Immunol (2012) 1.01

Identification and characterization of a dense cluster of placenta-specific cysteine peptidase genes and related genes on mouse chromosome 13. Genomics (2002) 1.00

Activin receptor signaling. Growth Factors (2004) 0.97

Role of dendritic cell maturity/costimulation for generation, homeostasis, and suppressive activity of regulatory T cells. Front Immunol (2011) 0.96

Efficient genetic modification of murine dendritic cells by electroporation with mRNA. Cancer Gene Ther (2002) 0.92

Tolerogenic dendritic cell-regulatory T-cell interaction and the promotion of transplant tolerance. Transplantation (2009) 0.92

Similar inflammatory DC maturation signatures induced by TNF or Trypanosoma brucei antigens instruct default Th2-cell responses. Eur J Immunol (2011) 0.91

Acquisition of T regulatory function in cathepsin L-inhibited T cells by eye-derived CTLA-2alpha during inflammatory conditions. J Immunol (2009) 0.90

Expression, purification, and inhibitory activities of mouse cytotoxic T-lymphocyte antigen-2alpha. Protein Expr Purif (2003) 0.88

Group 2 innate lymphoid cells in the regulation of immune responses. Adv Immunol (2014) 0.87

Basophils: in the spotlight at last. Nat Immunol (2008) 0.87

Cholera toxin prevents Th1-mediated autoimmune disease by inducing immune deviation. J Immunol (2004) 0.86

Regulation of TGF-β1-driven differentiation of human lung fibroblasts: emerging roles of cathepsin B and cystatin C. J Biol Chem (2014) 0.85

Cholera toxin activates nonconventional adjuvant pathways that induce protective CD8 T-cell responses after epicutaneous vaccination. Proc Natl Acad Sci U S A (2012) 0.85

Inhibition of cathepsin L-like cysteine proteases by cytotoxic T-lymphocyte antigen-2 beta. J Biol Chem (1994) 0.83

Nasal administration of cholera toxin (CT) suppresses clinical signs of experimental autoimmune encephalomyelitis (EAE). Vaccine (2001) 0.81

Cytotoxic T lymphocyte antigen-2 alpha induces apoptosis of murine T-lymphoma cells and cardiac fibroblasts and is regulated by cAMP/PKA. Cell Signal (2011) 0.81

Splenic marginal zone dendritic cells mediate the cholera toxin adjuvant effect: dependence on the ADP-ribosyltransferase activity of the holotoxin. J Immunol (2005) 0.81

Efficient responses to host and bacterial signals during Vibrio cholerae colonization. Gut Microbes (2013) 0.80

Direct interaction between cholera toxin and dendritic cells is required for oral adjuvant activity. Eur J Immunol (2013) 0.80

How quantitative differences in dendritic cell maturation can direct TH1/TH2-cell polarization. Oncoimmunology (2013) 0.79

There is an increase in expression of the cytotoxic T-lymphocyte antigen-2 alpha gene during pregnancy. Am J Obstet Gynecol (1996) 0.79

Dendritic and axonal localization of cytotoxic T-lymphocyte antigen-2 alpha protein in mouse brain. Brain Res (2008) 0.78

Induction of T regulatory cells by cytotoxic T-lymphocyte antigen-2α on corneal endothelial cells. Invest Ophthalmol Vis Sci (2011) 0.76

Subcutaneous cholera toxin exposure induces potent CD103⁺ dermal dendritic cell activation and migration. Eur J Immunol (2013) 0.75